Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,342,724
-$51,869 QoQ
Shares Held
55,761
+12.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,153
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Freestone Capital Holdings, LLC holds $84,369,882 across 11 Drug Manufacturers - General names. PFE ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,406 | $32,871,581 | |
| 2 | ABBV |
AbbVie Inc.
|
65,869 | $16,575,275 | |
| 3 | JNJ |
Johnson & Johnson
|
57,366 | $14,569,243 | |
| 4 | MRK |
Merck & Co., Inc.
|
79,532 | $10,219,862 | |
| 5 | AMGN |
Amgen Inc
|
11,780 | $4,265,773 | |
| 6 | NVO |
Novo Nordisk A S
|
37,304 | $1,788,353 | |
| 7 | PFE |
Pfizer Inc
This page
|
55,761 | $1,342,724 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,873 | $1,121,014 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,342,724 | 55,761 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $1,394,593 | 49,665 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,217,784 | 48,907 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $3,178,171 | 124,732 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,541,685 | 104,855 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $3,349,618 | 132,187 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,412,527 | 128,629 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $6,778,066 | 234,211 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,618,938 | 165,080 | Shares | Defined | 2024-11-22 | |
| 2024-03-31 | $3,956,650 | 142,582 | Shares | Defined | 2024-11-22 | |
| 2023-12-31 | $2,437,217 | 84,655 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,760,871 | 83,234 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,208,619 | 87,476 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $3,612,962 | 88,553 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,671,909 | 91,177 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,988,246 | 113,991 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $6,526,538 | 124,481 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $7,623,546 | 147,258 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $9,538,582 | 161,534 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,035,532 | 163,579 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,174,013 | 234,270 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,576,184 | 236,715 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,949,193 | 215,952 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,474,019 | 149,156 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $4,491,480 | 137,354 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $4,151,214 | 127,182 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||